Mylan Launches Generic Versions of Trilipix Caps
July 15, 2013 at 09:51 AM EDT
Mylan Inc. (Nasdaq: MYL ) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Fenofibric Acid Delayed-release Capsules, 45 mg and 135 mg. Fenofibric Acid Delayed-release Capsules, 45 mg and 135 mg, are the generic version of Abbott's Trilipix® Capsules, which are indicated as an adjunct to diet in combination with a
